e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
COPD: cardiovascular comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Structural and biochemical characteristics of subclinical atherosclerosis in COPD
M. Urban, L. Cekici, G. C. Funk, M. Wolzt, O. C. Burghuber, A. Valipour (Vienna, Austria)
Source:
Annual Congress 2010 - COPD: cardiovascular comorbidities
Session:
COPD: cardiovascular comorbidities
Session type:
E-Communication Session
Number:
5212
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Urban, L. Cekici, G. C. Funk, M. Wolzt, O. C. Burghuber, A. Valipour (Vienna, Austria). Structural and biochemical characteristics of subclinical atherosclerosis in COPD. Eur Respir J 2010; 36: Suppl. 54, 5212
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The subclinical atherosclerosis and its association to clinical features of stable COPD
Source: Annual Congress 2011 - COPD management
Year: 2011
Physiologic markers of small-airways disease and their clinical relevance
Source: Annual Congress 2013 –Small airways in asthma: from physiologic measures to clinical relevance
Year: 2013
Inflammatory phenotypes of severe exacerbation of COPD, a clinico-laboratory characterization.
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021
Phenotypic factors as predictors of thrombotic conditionsin patients with chronic obstructive disease
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
Evaluation of metabolic profile in patients with chronic obstructive pulmonary disease and correlation between the metabolic parameters and the severity of disease
Source: Eur Respir J 2006; 28: Suppl. 50, 625s
Year: 2006
Investigation of relationships between inflammation and brain disease in COPD
Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Year: 2018
Pathophysiological notions on the evolution of peripheral airways disease (PAD) to overt COPD
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010
Clinical and functional characteristics of patients with acute severe COPD with or without ischemic heart disease
Source: Eur Respir J 2006; 28: Suppl. 50, 162s
Year: 2006
The molecular and clinical diseasomeof comorbid diseases inchronic obstructive pulmonary disease
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Phenotypic characteristics of patients with arterial hypertension and chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012
Correlation between muscular dysfunction and vascular inflammation in COPD
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
Nutritional and systemic inflammatory parameters in patients with COPD exacerbation: relation with functional parameters
Source: Eur Respir J 2005; 26: Suppl. 49, 297s
Year: 2005
Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Prevalence and clinical relevance of comorbidities in IPF
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
Pathophysiological features of chronic obstructive pulmonary disease in obese patients
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017
Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients
Source: Eur Respir J 2014; 44: 951-962
Year: 2014
Structural brain changes related to disease duration in patients with asthma
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011
Molecular and cytological features of occupational chronic obstructive pulmonary disease in subjects exposed to different environmental factors
Source: International Congress 2015 – Occupational factors in COPD and bronchitis
Year: 2015
Longitudinal changes in structural abnormalities using MDCT in chronic obstructive pulmonary disease
Source: International Congress 2017 – Imaging markers for COPD and asthma
Year: 2017
Clinical characteristics of severe asthma subphenotypes
Source: Annual Congress 2012 - Asthma: assessment and treatment
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept